GliMR 2.0 NEWSLETTER #13
This is the newest newsletter of COST Action Glioma MR Imaging 2.0.
It’s been a while since our last newsletter and we have much to tell you! But first, grab your agenda and save the date September 28-30 to join us during our next annual meeting in Kuşadasi, Turkey (please don’t forget to pre-register, more details below).
We also need your help to make sure GliMR has enough funds for all the exciting activities being prepared for the next grant period (see details below).
In this newsletter, we tell you more about recent output and events, including what Hamail and Yeva did during their STSMs, how GliMR participated in this year’s ISMRM annual meeting and the ISMRM Iberian Chapter annual meeting. Additionally, if you would like to help out one of your fellow GliMR-members on a survey about fMRI, please see further details below.
Read our recent GliMR publications related to the MAGMA special issue and the reviews from our working groups, and get to know our 200th member (our researcher of the month)! Lastly, we say goodbye to Lydiane Hirschler and welcome Gilbert Hangel as the new leader of WG1.
If you have any updates that you would like to share with GliMR, please email WG5.
|
|
GliMR Annual Meeting
from 28 to 30 September 2022
in Kuşadası
Preliminary program and more information?
Visit our webpage!
|
|
PRE-REGISTER
We invite all of you who are planning to join our annual meeting to fill in a short preregistration form about your travel plans, to determine the level of reimbursement for travel for all attendees. DEADLINE: Friday 9 September 2022
SUBMISSIONS
Submissions via e-mail until Wednesday, August 17th, 2022 at 23.59h. GliMR abstract prizes will be awarded during the meeting.
Two types of abstracts can be submitted: a ‘classic abstract’ and a ‘project abstract’. All abstracts should be categorized in one of those four topics:
- Radiogenomics and imaging biomarker studies
- Data management and knowledge transfer
- Preclinical applications
- Other
- Pipeline submission (analysis pipeline or software)
Submissions via e-mail until Wednesday, August 17th, 2022 at 23.59h. Make sure you send a brief description about your analysis pipeline or software including MR modality/modalities of interest and (pre)clinical usability.
|
|
|
Help us fund our Action Register and apply for a WG in e-COST
Starting from this year, COST will allocate budget depending on the number of participants, registered in each working group on the e-COST platform. This is NEW since May 2022 and most of you are NOT YET registered within THIS system!!
Therefore, we would like to urge you to register on e-COST and apply for one of the working groups before August 15, using this link.
|
Do you use rsFMRI?
Fill in this survey!
We would like to ask for your support with participation in the following survey about your current use of rs-fMRI. It shouldn’t take more than a couple of minutes to complete, and it will help us get an updated picture of the use of this technique for research and clinical purposes globally.
The form will be distributed among members of the largest neuroimaging societies, but feel free to share it with other practicing neuroradiologists/imaging researchers if you wish to.
All answers will be anonymous and used for research purposes only.
The survey is available here.
For more information, please contact
Rui Duarte Armindo or Greg Zaharchuk.
|
|
|
Let’s stay in touch via Whatsapp
Join the Whatsapp group ‘GliMR – The one and only’
|
|
|
Short Term Scientific Missions
Hamail Ayaz and Yeva Prysiazhniuk traveled to another lab for a mission of high GliMR importance.
|
|
Hamail Ayaz
Perfusion MRI
for survival prediction
Hamail works at the Atlantic Technological University in Sligo, investigating predominant recurrent tumors and radiation necrosis for a selected glioma patient cohort.
During his STSM, he traveled to the Adnan Menderes Üniversitesi (Aydin) to gather both conventional and advanced perfusion MRI data to automatically segment and compare the region of interest using deep learning algorithms for survival prediction. 
|
Yeva Prysiazhniuk
Comparing DSC and ASL
for glioma
Yeva (Charles University, Prague) is investigating the clinical benefit of contrast (DSC) and no-contrast (ASL) perfusion MRI in diagnostics of glioma.
The STSM to the Oslo University Hospital established a start of the ongoing project in collaboration between Charles University and Oslo University Hospital, which focuses on the comparison of perfusion methods, their ability to differentiate tumor grades, and their predictive value in overall survival estimation. The aim of the project is to establish an optimal clinical approach for diagnostic brain tumor MR imaging.
|
|
Multi-delay ASL perfusion
imaging: impact of modeling dispersion and interaction with denoising strategies
SARA MONTEIRO, Instituto Superior Técnico, Universidade de Lisboa/Champalimaud Centre for the Unknown, Lisbon
The ITC grant allowed me to attend the Joint Annual Meeting ISMRM-ESMRMB & ISMRT 31st Annual Meeting in London, where I presented my poster entitled ‘Multi-delay ASL perfusion imaging: impact of modeling dispersion and interaction with denoising strategies’.
With this work, I aimed to study the influence of two denoising strategies, together with modelling bolus dispersion, on multi-delay ASL perfusion imaging in a group of cerebral small vessel disease patients and their age-matched
healthy controls. 
|
GliMR@ISMRM Iberian Chapter
GliMR participated at the 2nd Annual Meeting of the Iberian Chapter of ISMRM as an exhibitor and presenter!
This 2-day meeting was held in Lisbon in June and was attended by approximately 100 researchers and stakeholders.
Thank you for having us, @ISMRMIberian! 
|
|
|
GliMR’s recent publications
During GP3, GliMR published a Special Issue in MAGMA and several reviews.
In February, GliMR published a MAGMA Special Issue, collecting 16 articles of which 3 reviews. Many of those manuscripts are the result of the work of many of our GliMR members. We would like to thank our guest editors, Patricia C, Marion Smits, Matthias Van Osch, Bruno Costa, and Esther Warnert for their hard work in delivering this issue, and all our members submitting their work. More on the special issue can be found here. Additionally, a press release was published on this special issue, which can be found here. As part of the MAGMA Special Issue, GliMR has published an editorial on ‘Micro- and macroscale magnetic resonance imaging of glioma’. This editorial elaborates on the need for advanced MRI techniques in the diagnosis, prognosis, and follow-up of glioma patients and introduces GliMR as a network.
Working Group 3 is proud to announce the publication of its systematic review on the use of advanced MR imaging to evaluate cancer therapy side effects in non-targeted brain regions. This review is published in the 2021 Special Issue of Magnetic Resonance Materials in Physics, Biology, and Medicine (MAGMA). Read more here. Additionally, a press release was published on this special issue including this review, which can be found here.
- Researchers put forward evidence for use of advanced MRI techniques as brain cancer monitoring biomarkers
Recently, working group 1 published two reviews on the use of advanced MRI as a biomarker for treatment response monitoring. In part 1, the role of Perfusion and Diffusion techniques are evaluated, while part 2 covers Spectroscopy, Chemical Exchange Saturation, Multiparametric Imaging, and Radiomics.
Based on their findings, it appears that advanced MRI techniques show huge promise in treatment response assessment. The clinical readiness analysis highlights that most monitoring biomarkers require standardized international consensus guidelines, with more facilitation regarding technique implementation and reporting in the clinic.
Additionally, Kings College London launched a press release on this work, in collaboration with WG5. You can read the report, which has been picked up widely in the international press, here. Congratulations to the teams led by Otto Henriksen and Thomas Booth!
|
|
Thank you Lydiane and welcome Gilbert!
We thank Dr. Lydiane Hirschler for her excellent leadership, time and expertise in working group 1. After consultation within WG1, a replacement was found in Dr. Gilbert Hangel, from the Medical University of Vienna.
 
|
|
Researcher of the Month
Ricardo Loução
University Hospital of Cologne, Germany
GliMR Member #200
|
|
|
Ricardo is a biomedical engineer working at the University Hospital of Cologne, as part of the “functional imaging, neuromodulation, and clinical-experimental neurophysiology” team, led by Carolin Weiß Lucas. His primary research interests are: study of structural and functional connectivity reorganisation of brain functional networks in diseased condition, and the quantitative assessment of MR diffusion properties in brain tumours. Most of his research revolves around tumours, but he also perform structural connectivity analyses on patients of functional and psychiatric disorders. Ricardo’s work has been focused on translating research protocols into the clinical setting, with the primary goal of improving clinical assessment and outcome. To this end, he employs state-of-the-art MRI techniques, based on diffusion-weighted and BOLD signals, providing the clinicians with so-called “functional tractographies”, pinpointing relevant structures either at risk or to be targeted, which are crucial for surgical planning.
|
|
|
|
|
